Literature DB >> 7774443

[The effects of combined hepatectomy and immuno-chemotherapy on postoperative recurrence rate of primary liver cancer].

W Zhou1, M Wu, H Chen.   

Abstract

121 cases with primary liver cancer were divided into four groups: OP: resection only (30 cases); OC: combined operative resection and chemotherapy (27 cases); OI: combined operative resection and immunotherapy (31 cases); OI: combined operative resection and immuno-chemotherapy (33 cases). The results showed that one year recurrence rate was 56.7%, 40.7%, 32.3% and 27.3%, respectively. The recurrence rate of group OI and group OIC were significantly lower than that of group OP and group OC. It indicated that combined operation and immuno-chemotherapy is useful in preventing post operative recurrence.

Entities:  

Mesh:

Year:  1995        PMID: 7774443

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  3 in total

1.  Multiple courses of immunotherapy with different immune cell types for patients with hepatocellular carcinoma after microwave ablation.

Authors:  Ming-An Yu; Ping Liang; Xiao-Ling Yu; Zhi-Yu Han; Xue-Juan Dong; Y U Wang; Chao Cheng; Xin Li
Journal:  Exp Ther Med       Date:  2015-08-14       Impact factor: 2.447

2.  Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.

Authors:  Han-Yue Mo; Ying-Yang Liao; Xue-Mei You; Alessandro Cucchetti; Bao-Hong Yuan; Ru-Hong Li; Jian-Hong Zhong; Le-Qun Li
Journal:  PLoS One       Date:  2017-03-24       Impact factor: 3.240

Review 3.  Harms and benefits of adoptive immunotherapy for postoperative hepatocellular carcinoma: an updated review.

Authors:  Bao-Hong Yuan; Ru-Hong Li; Wei-Ping Yuan; Tian Yang; Tie-Jun Tong; Ning-Fu Peng; Le-Qun Li; Jian-Hong Zhong
Journal:  Oncotarget       Date:  2017-03-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.